胸肌前与胸肌下组织扩张器乳房再造:90天临床与健康相关生活质量结局的倾向性匹配分析
对2017年12月至2019年1月间接受即刻胸肌前或胸肌下组织扩张器乳房再造的患者行1:1倾向性匹配分析,238例匹配。胸肌前组术后第1至2天疼痛更低,但胸肌前组血清肿发生率更高,两组组织扩张器丢失率无差异。
要点
- 胸肌前组术后第1至2天疼痛低于胸肌下组,第3至10天无差异。
- 胸肌前组血清肿发生率高于胸肌下组(p < 0.001)。
- 两组组织扩张器丢失率无差异,BREAST-Q胸部生理健康评分无差异。
核心结论
- 胸肌前组织扩张器乳房再造患者术后早期疼痛更低,但无更长期的患者报告差异。
- 胸肌前再造患者血清肿发生率更高,但未转化为组织扩张器丢失率的差异。
- 需要长期分析临床和患者报告结局以全面了解胸肌前技术。
研究设计与样本
- 倾向性评分匹配分析(最近邻,1:1匹配,无放回),匹配变量包括年龄、体重指数、种族/民族、吸烟状态、化疗、放疗、保留乳头的乳房切除术和再造侧别。
- 纳入2017年12月至2019年1月间接受即刻胸肌前或胸肌下组织扩张器乳房再造的患者,初始队列921例,最终匹配238例。
- 匹配队列基线特征无差异。
主要发现
- 胸肌下组术后酮咯酸使用率高于胸肌前组(p = 0.048),其他术中及术后镇痛药使用无显著差异。
- 胸肌前组术后第1至2天疼痛低于胸肌下组,第3至10天无差异。
- BREAST-Q胸部生理健康评分两组无差异。
- 胸肌前组血清肿发生率高于胸肌下组(p < 0.001)。
- 组织扩张器丢失率两组无差异。
局限性
- 需要长期分析临床和患者报告结局以全面了解胸肌前技术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prepectoral placement of tissue expanders for two-stage implant-based breast reconstruction potentially minimizes chest wall morbidity and postoperative pain. The authors explored 90-day clinical and health-related quality-of-life outcomes for prepectoral versus subpectoral tissue expander breast reconstruction. METHODS: The authors conducted a propensity score-matching analysis (nearest neighbor, 1:1 matching without replacement) of patients who underwent immediate prepectoral or subpectoral tissue expander breast reconstruction between December of 2017 and January of 2019. Matched covariates included age, body mass index, race/ethnicity, smoking status, chemotherapy, radiotherapy, nipple-sparing mastectomy, and laterality of reconstruction. Outcomes of interest were perioperative analgesia use, 90-day postoperative patient-reported pain, complication rates, and BREAST-Q physical well-being of the chest scores. RESULTS: Of the initial cohort of 921 patients, 238 were propensity-matched and included in the final analysis. The matched cohort had no differences in baseline characteristics. Postoperative ketorolac (p = 0.048) use was higher in the subpectoral group; there were no other significant differences in intraoperative and postoperative analgesia use. Prepectoral patients had lower pain on postoperative days 1 to 2 but no differences on days 3 to 10. BREAST-Q physical well-being of the chest scores did not differ. Prepectoral patients had higher rates of seroma than subpectoral patients (p < 0.001). Rates of tissue expander loss did not differ. CONCLUSIONS: This matched analysis of 90-day complications found lower early postoperative pain in prepectoral tissue expander patients but no longer-term patient-reported differences. Although prepectoral reconstruction patients experienced a higher rate of seroma, this did not translate to a difference in tissue expander loss. Long-term analysis of clinical and patient-reported outcomes is needed to understand the full profile of the prepectoral technique. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Nelson JA, Shamsunder MG, Vorstenbosch J, et al. Prepectoral and Subpectoral Tissue Expander-Based Breast Reconstruction: A Propensity-Matched Analysis of 90-Day Clinical and Health-Related Quality-of-Life Outcomes. Plast Reconstr Surg. 2022. PMID: 35103644. doi:10.1097/PRS.0000000000008892
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。